Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/1434Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | REG NO. BQ0120002 | - |
| dc.date.accessioned | 2023-06-24T07:50:51Z | - |
| dc.date.available | 2023-06-24T07:50:51Z | - |
| dc.date.issued | 2023-06-15 | - |
| dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/1434 | - |
| dc.description.abstract | Introduction: Diabetes affects millions of patients worldwide and often co-exists with depression due to its higher prevalence in diabetic population as compared to general population. Treatment in diabetes is often life-long and is multimodal, that includes oral medications, injectables, dietary and lifestyle modifications. Presence of comorbid depression can interfere with maintaining compliance to the advised treatment plan Objectives: To assess the impact of depression on treatment compliance in patients with type II diabetes mellitus. Additionally, to assess the impact of depression on quality of life in patients with type II diabetes mellitus and to assess the prevalence of depression in patients with Type II diabetes mellitus | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | KLE Academy of Higher Education and Research, Belagavi | en_US |
| dc.subject | Keywords: Diabetes, depression, treatment compliance, quality of life, prevalence, MGLS | en_US |
| dc.title | The impact of depression on treatment Compliance in patients with type ii diabetes Mellitus a cross-sectional study | en_US |
| dc.type | Dissertations | en_US |
| Appears in Collections: | Psychiatry MD | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| BQ0120002.pdf | 4.3 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.